The Complement System and Antibody-Mediated Transplant Rejection - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Journal of Immunology Année : 2015

The Complement System and Antibody-Mediated Transplant Rejection


Complement activation is an important cause of tissue injury in patients with Ab-mediated rejection (AMR) of transplanted organs. Complement activation triggers a strong inflammatory response, and it also generates tissue-bound and soluble fragments that are clinically useful markers of inflammation. The detection of complement proteins deposited within transplanted tissues has become an indispensible biomarker of AMR, and several assays have recently been developed to measure complement activation by Abs reactive to specific donor HLA expressed within the transplant. Complement inhibitors have entered clinical use and have shown efficacy for the treatment of AMR. New methods of detecting complement activation within transplanted organs will improve our ability to diagnose and monitor AMR, and they will also help guide the use of complement inhibitory drugs.
Fichier principal
Vignette du fichier
IRMB 25_P50_The Complement System and Antibody Mediated Transplant Rejection_nihms-724258.pdf (439.44 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-01838588 , version 1 (17-03-2021)



Erik Stites, Moglie Le Quintrec, Joshua Thurman. The Complement System and Antibody-Mediated Transplant Rejection. Journal of Immunology, 2015, 195 (12), pp.5525 - 5531. ⟨10.4049/jimmunol.1501686⟩. ⟨hal-01838588⟩
57 Consultations
65 Téléchargements



Gmail Mastodon Facebook X LinkedIn More